March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
R.Ph. named director of UConn's Evidence-based Practice Center
December 10th 2007The Agency for Healthcare Research and Quality in the Department of Health and Human Services recently awarded the University of Connecticut a 5-year contract and up to $1 million per year to establish a new Evidence-based Practice Center.